Cargando…

CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways

BACKGROUND: CC-chemokine receptor 7 (CCR7), which plays an important role in cell directional movement, is highly expressed in various cancers and positively related to lymph node metastasis. The inflammatory cytokine tumour necrosis factor (TNF)-α promotes tumour progression and lymph node metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, HaiJie, He, CaiLong, Zhu, SiYuan, Zhang, YanHui, Wang, XiaoQian, She, FeiFei, Chen, YanLing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806413/
https://www.ncbi.nlm.nih.gov/pubmed/27009073
http://dx.doi.org/10.1186/s13046-016-0318-y
_version_ 1782423231835144192
author Hong, HaiJie
He, CaiLong
Zhu, SiYuan
Zhang, YanHui
Wang, XiaoQian
She, FeiFei
Chen, YanLing
author_facet Hong, HaiJie
He, CaiLong
Zhu, SiYuan
Zhang, YanHui
Wang, XiaoQian
She, FeiFei
Chen, YanLing
author_sort Hong, HaiJie
collection PubMed
description BACKGROUND: CC-chemokine receptor 7 (CCR7), which plays an important role in cell directional movement, is highly expressed in various cancers and positively related to lymph node metastasis. The inflammatory cytokine tumour necrosis factor (TNF)-α promotes tumour progression and lymph node metastasis in gallbladder cancer (GBC). However, the expression of CCR7 in GBC is unclear, and its role in the TNF-α-induced lymphatic metastasis of GBC requires further research. METHODS: The expression of CCR7 in clinical samples was detected by immunohistochemistry, and the relationship between CCR7 and clinicopathological factors or the TNF-α level of the bile was analyzed. After treatment with various concentrations of TNF-α, CCR7 expression in GBC cell lines was measured by Western blotting. The relative luciferase reporter assay, site-directed mutagenesis and chromatin immunoprecipitation were used to analyze the promoter activity and transcriptional regulation of CCR7. MAPKs inhibitors were used to explore the upstream signalling molecules of AP-1. We established a NOZ cell line stably expressing lentiviral CCR7 shRNA that effectively silenced the expression of CCR7, and to determine the role of TNF-α - CCR7 axis in the migration of GBC cells to the lymphatic system by transwell assays and animal experiments. RESULTS: CCR7 was highly expressed in GBC samples. Higher expression of CCR7 was associated with American Joint Committee on Cancer (AJCC) staging and lymph node metastasis. Moreover, we found that CCR7 expression in GBC tissue was positively correlated with the levels of TNF-α in the bile, and that TNF-α enhanced the promoter activity and protein expression of CCR7 through the “ERK1/2-AP-1” and “JNK-AP-1” pathways. Finally, we revealed that TNF-α could promote GBC cell migration to lymphatic endothelial cells or lymph nodes through upregulation of CCR7 in vitro and in vivo. CONCLUSIONS: Our study suggests that CCR7 is highly expressed in GBC, and mediates the TNF-α-induced lymphatic metastasis of GBC through the “TNF-α - ERK1/2 - AP-1 - CCR7” and “TNF-α - JNK - AP-1 - CCR7” pathways.
format Online
Article
Text
id pubmed-4806413
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48064132016-03-24 CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways Hong, HaiJie He, CaiLong Zhu, SiYuan Zhang, YanHui Wang, XiaoQian She, FeiFei Chen, YanLing J Exp Clin Cancer Res Research BACKGROUND: CC-chemokine receptor 7 (CCR7), which plays an important role in cell directional movement, is highly expressed in various cancers and positively related to lymph node metastasis. The inflammatory cytokine tumour necrosis factor (TNF)-α promotes tumour progression and lymph node metastasis in gallbladder cancer (GBC). However, the expression of CCR7 in GBC is unclear, and its role in the TNF-α-induced lymphatic metastasis of GBC requires further research. METHODS: The expression of CCR7 in clinical samples was detected by immunohistochemistry, and the relationship between CCR7 and clinicopathological factors or the TNF-α level of the bile was analyzed. After treatment with various concentrations of TNF-α, CCR7 expression in GBC cell lines was measured by Western blotting. The relative luciferase reporter assay, site-directed mutagenesis and chromatin immunoprecipitation were used to analyze the promoter activity and transcriptional regulation of CCR7. MAPKs inhibitors were used to explore the upstream signalling molecules of AP-1. We established a NOZ cell line stably expressing lentiviral CCR7 shRNA that effectively silenced the expression of CCR7, and to determine the role of TNF-α - CCR7 axis in the migration of GBC cells to the lymphatic system by transwell assays and animal experiments. RESULTS: CCR7 was highly expressed in GBC samples. Higher expression of CCR7 was associated with American Joint Committee on Cancer (AJCC) staging and lymph node metastasis. Moreover, we found that CCR7 expression in GBC tissue was positively correlated with the levels of TNF-α in the bile, and that TNF-α enhanced the promoter activity and protein expression of CCR7 through the “ERK1/2-AP-1” and “JNK-AP-1” pathways. Finally, we revealed that TNF-α could promote GBC cell migration to lymphatic endothelial cells or lymph nodes through upregulation of CCR7 in vitro and in vivo. CONCLUSIONS: Our study suggests that CCR7 is highly expressed in GBC, and mediates the TNF-α-induced lymphatic metastasis of GBC through the “TNF-α - ERK1/2 - AP-1 - CCR7” and “TNF-α - JNK - AP-1 - CCR7” pathways. BioMed Central 2016-03-24 /pmc/articles/PMC4806413/ /pubmed/27009073 http://dx.doi.org/10.1186/s13046-016-0318-y Text en © Hong et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hong, HaiJie
He, CaiLong
Zhu, SiYuan
Zhang, YanHui
Wang, XiaoQian
She, FeiFei
Chen, YanLing
CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
title CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
title_full CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
title_fullStr CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
title_full_unstemmed CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
title_short CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
title_sort ccr7 mediates the tnf-α-induced lymphatic metastasis of gallbladder cancer through the “erk1/2 - ap-1” and “jnk - ap-1” pathways
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806413/
https://www.ncbi.nlm.nih.gov/pubmed/27009073
http://dx.doi.org/10.1186/s13046-016-0318-y
work_keys_str_mv AT honghaijie ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways
AT hecailong ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways
AT zhusiyuan ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways
AT zhangyanhui ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways
AT wangxiaoqian ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways
AT shefeifei ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways
AT chenyanling ccr7mediatesthetnfainducedlymphaticmetastasisofgallbladdercancerthroughtheerk12ap1andjnkap1pathways